NEW YORK, April 29 (GenomeWeb News) - Shimadzu and the Institute of Medical Science at the University of Tokyo plan to jointly conduct genomic and proteomic analyses with the goal of identifying new disease-related genes and biomarkers.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.